Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2 (ASTANA)

Instituto Brasileiro de Controle do Cancer

Status: Unknown

Conditions: Oncology; Surgery; SARS-CoV-2

Treatments: Diagnostic Test: PT-PCR test for SARS-CoV-2

Study type: Observational

Funder types: Other

Identifiers

NCT04434261

33467320.0.0000.0072

Details and patient eligibility

About

To evaluate the incidence of patients with a positive test for SARS-CoV-2, performed in the preoperative screening for patients treated at the institution

Full description

Cohort, prospective, observational study to evaluate the incidence of asymptomatic patients with a positive SARS-CoV-2 test detected in the preoperative screening program of the institution.

Enrollment: 1,500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with elective surgery scheduled at the IBCC, including those diagnosed with any type of cancer;
• Patients who will undergo the screening test for SARS-COV-2 by RT-PCR (nasal swab), according to the guidelines and protocol of the hospital

Exclusion criteria

• Urgent or emergency surgery;
• Screening test for SARS-COV-2 not performed
• Incomplete data in the institutional database

Trial design

1,500 participants in 1 patient group

Patients tested for SARS-CoV-2

Description:

Patients who underwent the preoperative screening program for SARS-CoV-2

Treatment:

Diagnostic Test: PT-PCR test for SARS-CoV-2